Bronchiolitis obliterans syndrome (BOS), bronchiolitis obliterans organizing pneumonia (BOOP), and other late-onset noninfectious pulmonary complications following allogeneic hematopoietic stem cell transplantation.
about
The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host DiseaseBronchiolitis obliterans organizing pneumonia, 25 years: a variety of causes, but what are the treatment options?Chronic graft-versus-host disease (GVHD) in children.Stem cells in clinical practice: applications and warnings.Bronchiolitis obliterans syndrome epidemiology after allogeneic hematopoietic cell transplantation.How I treat late effects in adults after allogeneic stem cell transplantation.Health-related quality of life in patients who develop bronchiolitis obliterans syndrome following allo-SCT.Prognostic implications of the NIH consensus criteria in children with chronic graft-versus-host diseaseLong-term health impacts of hematopoietic stem cell transplantation inform recommendations for follow-up.A "window of opportunity" for patients with late-onset pulmonary dysfunction after allogeneic hematopoietic cell transplantationNational Cancer Institute-National Heart, Lung and Blood Institute/pediatric Blood and Marrow Transplant Consortium First International Consensus Conference on late effects after pediatric hematopoietic cell transplantation: long-term organ damage aEvaluating the impact of antithymocyte globulin on lung function at 1 year after allogeneic stem cell transplantationBlood and marrow transplant clinical trials network state of the Science Symposium 2014Long-term complications and side effects after allogeneic hematopoietic stem cell transplantation: an updateAn official American Thoracic Society research statement: noninfectious lung injury after hematopoietic stem cell transplantation: idiopathic pneumonia syndrome.Protective role of T-bet and Th1 cytokines in pulmonary graft-versus-host disease and peribronchiolar fibrosis.Acute graft-versus-host disease and bronchiolitis obliterans after autologous stem cell transplantation in a patient with multiple myeloma.Pulmonary rehabilitation for bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation.Sirolimus associated pneumonitis after nonmyeloablative peripheral blood stem cell transplant for sickle cell disease.Chronic Graft-versus-Host Disease--implementation of the National Institutes of Health Consensus Criteria for Clinical TrialsMeasuring therapeutic response in chronic graft-versus-host disease. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. The 2014 Response Criteria Working Group reporLate Complications in acute Leukemia patients following HSCT: A single center experiencePredictive value of bronchiolitis obliterans syndrome stage 0p in chronic graft-versus-host disease of the lung.Cytomegalovirus pneumonia in hematopoietic stem cell recipients.A Critical Care and Transplantation-Based Approach to Acute Respiratory Failure after Hematopoietic Stem Cell Transplantation in Children.Pulmonary symptoms measured by the national institutes of health lung score predict overall survival, nonrelapse mortality, and patient-reported outcomes in chronic graft-versus-host disease.How we approach patient evaluation for hematopoietic stem cell transplantation.Late complications after hematopoietic stem cell transplantation.Preventing and managing bronchiolitis obliterans syndrome after allogeneic hematopoietic cell transplantation.Solid organ transplantation following end-organ failure in recipients of hematopoietic stem cell transplantation in children.Lung transplantation following hematopoietic stem cell transplantation: report of two cases and systematic review of literature.State-of-the-art acute and chronic GVHD treatment.The role of biomechanical anatomical modeling via computed tomography for identification of restrictive allograft syndrome.Recommended screening and preventive evaluation practices of adult candidates for hematopoietic stem cell transplantation.A call to arms: a critical need for interventions to limit pulmonary toxicity in the stem cell transplantation patient population.Bone marrow transplantation alters lung antigen-presenting cells to promote TH17 response and the development of pneumonitis and fibrosis following gammaherpesvirus infection.Pulmonary Clinicopathological Correlation after Allogeneic Hematopoietic Stem Cell Transplantation: An Autopsy Series.A case-control study of bronchiolitis obliterans syndrome following allogeneic hematopoietic stem cell transplantation.Loss of CCR2 signaling alters leukocyte recruitment and exacerbates γ-herpesvirus-induced pneumonitis and fibrosis following bone marrow transplantation.Gut Microbiota Predict Pulmonary Infiltrates after Allogeneic Hematopoietic Cell Transplantation.
P2860
Q28076264-64F8865C-B5E4-44B0-91A9-4B9901D1956BQ28241636-8F3DE460-5CF0-4DBB-81B9-C9E8CB139C4BQ33857680-4248B1B8-9C3A-4953-97D0-FB851885FD14Q34552765-3F354DEA-0CB2-4C7F-A108-E881AE4C4AFEQ34700473-DF227065-A76B-460C-A1FC-87D3E34B35C5Q34707208-BEF0050B-C30B-4048-8405-677365B0DD49Q35153996-B4FBEAA5-F0F7-45EA-B162-18C8C6677DBCQ35176287-9D3A4839-1406-44F7-BFE2-E8A157E63D90Q35184667-AAF7EA0C-49BA-49FE-AC59-B8157C471519Q35445239-4FA95E21-902F-47D7-BE75-572970D7979BQ35549037-303F8DB2-63C1-4591-9DE2-0E61ABF54048Q35574785-AA2E3302-7D17-46B8-A927-2CCE802E1FD7Q35591760-E0344FA2-5F3F-4B1A-BBB2-9BADC31A2117Q35664284-A99FD242-5F97-4647-8B88-3EC99968EBE7Q35694784-7BA7F3D8-891B-4D20-90C0-9A69D43D6AADQ35813877-60C4F480-3DD8-43F1-9B0D-69073A902235Q35841771-89A5B9E6-873F-4F83-9CBB-1749C4AC057DQ36044412-6CC876EA-F94C-4B0E-82E8-9938E508544AQ36517807-D0B832E6-A5FD-48CA-975A-8F2E45CA4541Q36540762-0691B4F7-4B8D-41D0-B721-456A67A0F088Q36554724-93412F7B-B1D8-4349-8ADB-2C71AF36D291Q36759562-D6707A01-CD6D-4CA1-86E8-F3F5B2CA8EF2Q37146140-C4F72B2A-122F-46FB-BC9A-FC78CFB823CFQ37179131-65D098F0-A175-43C5-A09C-3707376B3335Q37276584-8AA3A3F6-500C-45A5-A17A-21C5262AEE73Q37680499-EFAE5D03-265B-4E48-8AC3-15156EC7402DQ37755957-E509A335-C430-4E16-BA76-78672D159C7AQ37810122-B353BAAF-896F-47A1-8D5A-E2CF58116082Q37846706-CFA3E639-D6FD-4369-9239-3B77930A8453Q38129306-C6566085-F578-4B0F-A88D-472749F48944Q38206283-4B5CE9E7-9460-496C-A115-3CD39DE26E65Q38416376-780D9C6E-9F77-4457-A4CD-A975A0CE1096Q38704379-9AA40609-25E1-4CA6-AF8F-6D317FEFC13DQ38937601-31D83199-7111-40AA-BED4-DD7DE4F8996FQ39041930-F6E961CB-A2FE-444F-A94A-BD29166A3D95Q39052615-D6FEBCB9-985E-4BC9-AF7D-DDC835B0A994Q39408929-F76B589B-AE1A-4F4D-85E3-880EDD76189FQ39441064-0856EE32-07DD-4DF2-B957-04E1CEDF95F0Q39569560-541343C9-5C6B-44ED-ADF3-536D324EC14FQ40787967-29C817C6-BE92-4F7E-9675-9DC7A8E3F056
P2860
Bronchiolitis obliterans syndrome (BOS), bronchiolitis obliterans organizing pneumonia (BOOP), and other late-onset noninfectious pulmonary complications following allogeneic hematopoietic stem cell transplantation.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Bronchiolitis obliterans syndr ...... tic stem cell transplantation.
@en
type
label
Bronchiolitis obliterans syndr ...... tic stem cell transplantation.
@en
prefLabel
Bronchiolitis obliterans syndr ...... tic stem cell transplantation.
@en
P2093
P1476
Bronchiolitis obliterans syndr ...... tic stem cell transplantation.
@en
P2093
Gregory Yanik
Kenneth R Cooke
Satoshi Yoshihara
Shin Mineishi
P304
P356
10.1016/J.BBMT.2007.05.001
P577
2007-07-01T00:00:00Z